HS Icon Vaccines, blood, antisera, toxins and cultures in  Flag Germany

2020
Exports | Imports
: $34.1B | $25.5B, World Rnk 1 / 193
Flag Rnk 4 / 1217 | World Rnk 2 / 221
Flag Rnk 5 / 1214

2019 - 2020
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $2.72B | $1.27B, United States |  Ireland

2020
ECONOMIC COMPLEXITY of Germany
: 1.88, Rnk 4 / 127

2020
PRODUCT COMPLEXITY  IN Vaccines, blood, antisera, toxins and cultures
: 1.23, Rnk 112 / 1029

Exports In 2020, Germany exported $34.1B in Vaccines, blood, antisera, toxins and cultures, making it the 1st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 4th most exported product in Germany. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Germany are: United States ($7.07B), Netherlands ($4.67B), Switzerland ($3.26B), Italy ($2.32B), and Belgium ($1.53B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Germany between 2019 and 2020 were United States ($2.72B), Switzerland ($631M), and Belgium ($419M).

Imports In 2020, Germany imported $25.5B in Vaccines, blood, antisera, toxins and cultures, becoming the 2nd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most imported product in Germany. Germany imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($5.95B), United States ($4.11B), Ireland ($2.38B), Netherlands ($2.31B), and Belgium ($1.95B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Germany between 2019 and 2020 were Ireland ($1.27B), Switzerland ($1.2B), and South Korea ($926M).

N/A

Subnational Monthly Trade

#permalink to section
View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Historical Data

#permalink to section
Value
Compare to

EXPORTS (2020): $34.1B

IMPORTS (2020): $25.5B

NET TRADE (2020): $8.6B

In 2020, Germany exported $34.1B in Vaccines, blood, antisera, toxins and cultures. The main destinations of Germany exports on Vaccines, blood, antisera, toxins and cultures were United States ($7.07B), Netherlands ($4.67B), Switzerland ($3.26B), Italy ($2.32B), and Belgium ($1.53B).

In 2020, Germany imported $25.5B in Vaccines, blood, antisera, toxins and cultures, mainly from Switzerland ($5.95B), United States ($4.11B), Ireland ($2.38B), Netherlands ($2.31B), and Belgium ($1.95B).

Explore Visualizations

Flow

THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Germany WERE (2019 - 2020):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Germany WERE (2019 - 2020):

Explore Visualizations

Market Concentration

#permalink to section
View
Flow
Type

In 2020, Germany's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:

In 2020, Germany's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations